Tender for Generic Drugs under the Procurement Plan for Drug Supply, 4th Round, 2026

This tender, identified by notification number IB2600089730, is for the procurement of generic drugs. It is part of the planned procurement activities for the fourth round of drug supply in 2026. The tender falls under the HH (likely Healthcare or Pharmaceuticals) sector and is classified as an 'es-ct-contract', indicating a contract for goods. The objective is to secure a supply of essential generic medications to meet healthcare needs. This procurement process is crucial for ensuring the availability of affordable and effective medicines. Bidders are expected to supply drugs that meet stringent quality standards and regulatory requirements. The tender likely involves competitive bidding to obtain the best value for money while ensuring the reliability and quality of the pharmaceutical products supplied.

This is a supplies contract in the health and medical services, information and communication technology and general supplies sectors, with a focus on Hospitals and Pharmaceuticals. Located in Vietnam, Asia, this opportunity is open to firms and consortiums.

Published through Vietnam e-GP, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.